SCHEDULE 7Fees
PART 2Fees relating to marketing authorisations
Decentralised pharmaceutical application where the United Kingdom is the reference member State
8.
The fee for a decentralised application for a pharmaceutical product where the United Kingdom is the reference member State is the same as for a national application as set out in the table in paragraph 7, with the addition of the fees in the following table.
Fees for decentralised pharmaceutical application where the United Kingdom is the reference member State
Application | Additional fee for a pharmacologically equivalent product (£) | Additional fee otherwise (£) | |
|---|---|---|---|
Food-producing animal: one member State: | 5,230 | 3,705 | |
Non-food-producing animal: one member State: | 3,985 | 3,220 | |
Each additional member State: | 530 | 530 | |
Simultaneous application: fee for each additional product in the application: | |||
one member State: | 6,670 | 6,670 | |
each additional member State: | 120 | 120 | |